Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.5 EUR | 0.00% | 0.00% | +3.73% |
Apr. 22 | BioXcel Therapeutics to Launch At-Home Trial of Potential Bipolar, Schizophrenia Agitation Treatment | MT |
Apr. 11 | Gerresheimer shares down on outlook, but key contracts confirmed | RE |
Evolution of the average Target Price on Administer Oyj
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
EPS Revisions
- Stock Market
- Equities
- ADMIN Stock
- Consensus Administer Oyj